Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.
The Journal of rheumatology
OBJECTIVE: Establishing a research agenda on standardizing pain measurement in clinical trials in rheumatic and musculoskeletal diseases (RMD).
METHODS: Discussion during a meeting at the Outcome Measures in Rheumatology (OMERACT) 2018, prepared by a systematic review of existing core outcome sets and a patient online survey.
RESULTS: Several key questions were debated: Is pain a symptom or a disease? Are pain core (sub)domains consistent across RMD? How to account for pain mechanistic descriptors (e.g., central sensitization) in pain measurement?
CONCLUSION: Characterizing and assessing the spectrum of pain experience across RMD in a standardized fashion is the objective of the OMERACT Pain Working Group.
Orthopedics & Sports Medicine
Chiarotto, Alessandro; Kaiser, Ulrike; Choy, Ernest; Christensen, Robin; Conaghan, Philip G; Cowern, Mary; Gill, Michael; de Wit, Maarten; Gargon, Elizabeth; Horgan, Ben; Kirkham, Jamie J; Simon, Lee S; Singh, Jasvinder A; Tugwell, Peter; Turk, Dennis C; and Mease, Philip, "Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018." (2019). Articles, Abstracts, and Reports. 1502.